Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
McKesson
Teva
Argus Health
AstraZeneca

Generated: August 20, 2019

DrugPatentWatch Database Preview

SUNOSI Drug Profile

  Try a free trial


See Plans and Pricing

« Back to Dashboard

When do Sunosi patents expire, and when can generic versions of Sunosi launch?

Sunosi is a drug marketed by Jazz and is included in one NDA. There are four patents protecting this drug.

This drug has twenty-four patent family members in fifteen countries.

The generic ingredient in SUNOSI is solriamfetol. One supplier is listed for this compound. Additional details are available on the solriamfetol profile page.

Summary for SUNOSI
International Patents:24
US Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 3
Patent Applications: 28
Drug Prices: Drug price information for SUNOSI
DailyMed Link:SUNOSI at DailyMed
Drug patent expirations by year for SUNOSI
Generic Entry Opportunity Date for SUNOSI
Generic Entry Date for SUNOSI*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for SUNOSI
(2R)-2-amino-3-phenylpropyl carbamate
(R)-2-amino-3-phenylpropyl carbamate
[(2R)-2-amino-3-phenylpropyl] carbamate
178429-62-4
939U7C91AI
ADX-N05
Adx-N05 free base
ADXN05
Benzenepropanol, beta-amino-, 1-carbamate, (betaR)-
Benzenepropanol, beta-amino-, carbamate (ester), (R)-
GTPL10342
JZP-110
JZP110
O-Carbamoyl-(D)-phenylalaninol
SCHEMBL2739637
Solriamfetol
Solriamfetol [USAN]
UCTRAOBQFUDCSR-SECBINFHSA-N
UNII-939U7C91AI
ZINC34278783

US Patents and Regulatory Information for SUNOSI

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jazz SUNOSI solriamfetol TABLET;ORAL 211230-001 Jun 17, 2019 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jazz SUNOSI solriamfetol TABLET;ORAL 211230-002 Jun 17, 2019 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jazz SUNOSI solriamfetol TABLET;ORAL 211230-001 Jun 17, 2019 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Jazz SUNOSI solriamfetol TABLET;ORAL 211230-002 Jun 17, 2019 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jazz SUNOSI solriamfetol TABLET;ORAL 211230-001 Jun 17, 2019 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jazz SUNOSI solriamfetol TABLET;ORAL 211230-001 Jun 17, 2019 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Teva
Cantor Fitzgerald
Medtronic
Covington
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.